Results 91 to 100 of about 42,426 (141)

Prescribing Trends for Bipolar Disorder Drugs in Alberta, Canada Between 2008 and 2021: Tendances en matière de prescription de médicaments pour le trouble bipolaire en Alberta, au Canada, entre 2008 et 2021. [PDF]

Can J Psychiatry
Shafiq S, Ronksley PE, Elliott MJ, Bulloch AGM, Patten SB.   +4 more
europepmc   +1 more source

Exploring current approaches towards patient prioritisation for clinical pharmacy services in UK mental health inpatient care. [PDF]

BMC Psychiatry
Alshaikhmubarak FQ, Keers RN, Brown P, Lewis PJ.   +3 more
europepmc   +1 more source

Comparing the effect of sympathomimetic/anticholinergic psychotropic drugs with that of non-sympathomimetic/anticholinergic psychotropic drugs on IOP and angle parameters among patients on long-term therapy. [PDF]

Indian J Ophthalmol
Behera G, Lenin J, Bharadwaj B, Mahalingam K, Ram A, Natarajan K, Bascarane S, Kaliaperumal S, Dolli K.   +8 more
europepmc   +1 more source

Self-assembled nanomaterials enable extended lithium release.

J Mater Chem B
Zamani M, Monir K, Furst AL.
europepmc   +1 more source

The LATTICE Study: Design of a pilot feasibility randomized controlled trial of lithium to delay cognitive decline in mild cognitive impairment. [PDF]

Alzheimers Dement (N Y)
Gildengers AG, Ibrahim TS, Zeng X, Aizenstein HJ, Alkhateeb SK, Anderson SJ, Chu C, Diaz JL, Emanuel JE, Karikari TK, Li J, Lopez OL, Lopresti BJ, Royse SK, Sajewski AN, Santini T, Weinstein AM, Wu M, Butters MA.   +18 more
europepmc   +1 more source

Elevated Levels of Plasma Phosphorylated Tau 181 (pTau181) Associated With Opioid Use to Guide Medication Titration Over a Clinically Relevant Short Timescale. [PDF]

Cureus
Hanson EJ, Berner KF, Berner J.
europepmc   +1 more source